David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPX
2301
DELISTED
GP Strategies Corp.
GPX
| $1.5M | ﹤0.01% |
123,848
+434
| +0.4% | +$6.33K |
|
2302
Buckle
BKE
$2.22B
| $1.5M | ﹤0.01% |
80,315
+63,078
| +366% | +$1.15M |
|
|
TUP
2303
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $1.5M | ﹤0.01% |
58,800
+1,000
| +2% | +$30.5K |
|
|
IMDZ
2304
DELISTED
Immune Design Corp.
IMDZ
| $1.5M | ﹤0.01% |
257,007
+51,859
| +25% | +$177K |
|
|
INSY
2305
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.5M | ﹤0.01% |
324,957
-187,487
| -37% | -$888K |
|
2306
United Rentals
URI
$65.2B
| $1.5M | ﹤0.01% |
13,113
-78,062
| -86% | -$9.64M |
|
|
SUPV
2307
Grupo Supervielle
SUPV
$737M
| $1.5M | ﹤0.01% |
+246,102
| New | +$2.2M |
|
2308
Applied Industrial Technologies
AIT
$12.4B
| $1.5M | ﹤0.01% |
25,137
-12,246
| -33% | -$710K |
|
|
CTXS
2309
CALL
DELISTED
Citrix Systems Inc
CTXS
| $1.5M | ﹤0.01% |
15,000
-10,000
| -40% | -$1.04M |
|
2310
CALL
T-Mobile US
TMUS
$191B
| $1.49M | ﹤0.01% |
21,600
-8,400
| -28% | -$588K |
|
|
KE
2311
Kimball Electronics
KE
$581M
| $1.49M | ﹤0.01% |
96,246
+4,562
| +5% | +$73.4K |
|
|
CHK
2312
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $1.49M | ﹤0.01% |
2,400
+541
| +29% | +$303K |
|
2313
Sonic Automotive
SAH
$2.48B
| $1.48M | ﹤0.01% |
99,996
-46,468
| -32% | -$697K |
|
2314
Worthington Enterprises
WOR
$2.81B
| $1.48M | ﹤0.01% |
64,301
+16,235
| +34% | +$372K |
|
|
CHMI
2315
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $1.48M | ﹤0.01% |
85,728
+22,398
| +35% | +$411K |
|
2316
Cameco
CCJ
$46B
| $1.48M | ﹤0.01% |
125,259
-122,846
| -50% | -$1.48M |
|
2317
QCR Holdings
QCRH
$1.66B
| $1.48M | ﹤0.01% |
43,532
+1,161
| +3% | +$39.9K |
|
2318
RLJ Lodging Trust
RLJ
$1.76B
| $1.47M | ﹤0.01% |
83,913
+8,769
| +12% | +$160K |
|
2319
Digimarc Corp
DMRC
$144M
| $1.47M | ﹤0.01% |
46,881
-666
| -1% | -$16.5K |
|
2320
Exponent
EXPO
$3.38B
| $1.47M | ﹤0.01% |
25,482
+5,517
| +28% | +$298K |
|
2321
PUT
AerCap
AER
$23.1B
| $1.47M | ﹤0.01% |
31,500
| – | – |
|
|
PYX
2322
DELISTED
Pyxus International, Inc.
PYX
| $1.47M | ﹤0.01% |
61,365
-9,413
| -13% | -$196K |
|
2323
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $1.47M | ﹤0.01% |
+13,580
| New | +$1.44M |
|
2324
Texas Roadhouse
TXRH
$13.2B
| $1.46M | ﹤0.01% |
23,498
-6,359
| -21% | -$398K |
|
2325
Dorman Products
DORM
$3.82B
| $1.46M | ﹤0.01% |
16,580
+565
| +4% | +$49.1K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.